Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

Clinical trial NCT00119171 · COMPLETED

Trial details

NCT number: NCT00119171
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Cancer

Start date: 2004-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.